A study conducted in Europe over more than two decades found 13 percent fewer deaths among men aged 55 to 69 who underwent regular antigen screening for prostate cancer

Cancer & Oncology

Cancer treatment, oncology drug access, hematologic malignancies, and cancer drug policy.

208 claims·153 news stories

54 claims